A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction
Clinical trial NCT07304843 · RECRUITING
Trial details
- NCT number
- NCT07304843
- Sponsor
- Umecrine Cognition AB
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-14
- Primary completion
- 2026-09-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.